Selenium-dependent enzyme biosynthesis

Selenium-dependent enzyme biosynthesis" is not a specific molecular target but rather refers to the biological process by which selenium is incorporated into selenoproteins—enzymes that require selenium for their catalytic activity. In animals, including humans, this process involves the incorporation of the amino acid selenocysteine into proteins during translation. Key enzymes in this pathway include selenophosphate synthetase 2, which synthesizes selenophosphate as a selenium donor for selenocysteine formation on specialized tRNA molecules[2]. The resulting selenoenzymes play critical roles in antioxidant defense (e.g., glutathione peroxidases), redox regulation (e.g., thioredoxin reductases), thyroid hormone metabolism (deiodinases), and other essential cellular processes. Disruption in this biosynthetic pathway can lead to impaired antioxidant capacity and increased susceptibility to diseases linked with oxidative stress or abnormal thyroid function. While some drugs such as ebselen act as mimetics of these enzymes' activities, "Selenium-dependent enzyme biosynthesis" itself is not considered a direct therapeutic target but rather an essential cellular process underpinning multiple health outcomes[1][2][3].

Drugs like ebselen mimic the activity of selenium-dependent enzymes, catalyzing the reduction of hydrogen peroxide and organic hydroperoxides, thereby protecting cells from oxidative damage[3].